Merit Medical Systems (FRA:MM3) Current Accrued Expense: €149 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:MM3 Merit Medical Systems Inc FRA:MM3
88 GF Score
Price €78.00
GF Value €82.96
! 2 Warning Signs
View Full Analysis

What is Merit Medical Systems Current Accrued Expense?

Merit Medical Systems FRA:MM3 +1.96% 88 Current Accrued Expense is €149 Mil as of Jun. 2026. GuruFocus rates FRA:MM3 with a GF Score™ of 88/100 and a GF Value™ of €82.96. The stock has 2 warning signs investors should review.

Merit Medical Systems's Current Accrued Expense for the quarter that ended in Jun. 2026 was €149 Mil.

Merit Medical Systems's quarterly Current Accrued Expense declined from Dec. 2025 (€126 Mil) to Mar. 2026 (€106 Mil) but then increased from Mar. 2026 (€106 Mil) to Jun. 2026 (€149 Mil).

Merit Medical Systems's annual Current Accrued Expense increased from Dec. 2023 (€100 Mil) to Dec. 2024 (€117 Mil) and increased from Dec. 2024 (€117 Mil) to Dec. 2025 (€126 Mil).

Merit Medical Systems Current Accrued Expense Related Terms

Merit Medical Systems Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Merit Medical Systems's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merit Medical Systems Current Accrued Expense Chart

Merit Medical Systems Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 130.58 105.82 100.10 116.65 125.51

Merit Medical Systems Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 121.56 125.57 125.51 105.98 149.46
FRA:MM3
88GF Score
Merit Medical Systems Inc FRA:MM3
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Merit Medical Systems Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of €149 Mil mean?
Merit Medical Systems (FRA:MM3) has a Current Accrued Expense of €149 Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Merit Medical Systems and its competitors.
Is Merit Medical Systems' Current Accrued Expense too high?
Merit Medical Systems' current Current Accrued Expense is €149 Mil. Overall, Merit Medical Systems has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Merit Medical Systems' Current Accrued Expense compare to NVST and MMED?
Merit Medical Systems' Current Accrued Expense of €149 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Devices & Instruments company?
A good Current Accrued Expense depends on the Medical Devices & Instruments industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Merit Medical Systems and its competitors. Merit Medical Systems's current Current Accrued Expense is €149 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Merit Medical Systems stock overvalued right now?
Merit Medical Systems (FRA:MM3) has a current Current Accrued Expense of €149 Mil. The stock's GF Value™ is €82.96, compared to a current price of €78.00 — trading 6% below its estimated fair value. The current Current Accrued Expense is €149 Mil. Merit Medical Systems' overall GF Score™ is 88/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Merit Medical Systems (FRA:MM3), the current Current Accrued Expense is €149 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Merit Medical Systems (FRA:MM3) Overvalued in 2026?

Based on GuruFocus' analysis, Merit Medical Systems stock appears to be undervalued. The current stock price of €78.00 is trading 6% below its estimated GF Value™ of €82.96.

Key valuation signals for FRA:MM3:

  • Current Accrued Expense: €149 Mil
  • GF Value™: €82.96 vs. price of €78.00 (6% below fair value)
  • GF Score™: 88/100 with 2 warning signs

No single metric tells the full story. See the FRA:MM3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Merit Medical Systems Business Description

Other Exchanges MMSI:USA
Address 1600 West Merit Parkway, South Jordan, UT, USA, 84095
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.
88GF Score

Get the complete analysis for FRA:MM3

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€78.00
Price
€82.96
GF Value